ARCHIVES

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

Three-Quarters of P01 $$ Goes To Translational Grants, NCI Finds

October 2, 1992

In Brief: Francis Giles named deputy director of Lurie Cancer Center

October 17, 2014

Women With Early Breast Cancer Can Wait Up To 12-Weeks For Chemo, Study Finds

October 27, 2006

Two Phase II Studies of Ibrutinib Deliver High Response Rates

December 27, 2013

NCA Uneasy Over Possible NIH Takeover Of FCRC, But It Won’t Happen

June 13, 1980

High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer

January 25, 2008